Business Wire
Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting
📊
AI Sentiment
Positive
7/10
Enanta Pharmaceuticals Inc. News
Latest updates and market news for ENTA
5 news
Feb 6 - Feb 12, 2026
Page 1
Zacks
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates
📊
AI Sentiment
Positive
6/10
MT Newswires
Enanta Pharmaceuticals Fiscal Q1 Loss Narrows, Revenue Rises
📉
AI Sentiment
Negative
3/10
Associated Press Finance
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot
📉
AI Sentiment
Negative
3/10
Share this news page